chevron_leftBack
As of 13 June 2026, Microbot Medical Inc. has a market cap of $137.0M USD, ranking #23430 globally and #3703 in the United States.
It ranks #2102 in the Healthcare sector, and #408 in the Biotechnology industry.
Key Stats
Market Cap
$137.0MUSD
Enterprise Value
$59.61MUSD
EBITDA (TTM)
-$14.7MUSD
Net Income (TTM)
-$13.14MUSD
PB Ratio
1.8
Company Profile
Country (HQ)
Sector
Healthcare
Industry
Biotechnology
CEO
Harel Gadot
open_in_new
Employees
43
Founded
2010
Website
microbotmedical.com
open_in_new
| 1d | 1w | 1m | 3m | 6m | 1y |
|---|---|---|---|---|---|
| -2.9% | -5.1% | -15% | 7.4% | -6.8% | -24% |
News
Loading...
MBOT Analyst Forecasts
Loading...
Markets
| Exchange | Ticker | Price |
|---|---|---|
|
MBOT
Microbot Medical Inc
ISIN: US59503A2042
Shares Out.:
Shares Outstanding:
67.165M1
Shares Float:
61.026M2
TV:
TradingView:
SA:
Stock Analysis:
YF:
Yahoo Finance:
GF:
Google Finance:
NQ:
NASDAQ:
BA:
Barron's:
MS:
Morningstar:
|
2.04 USD |
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.
About Microbot Medical Inc.
Microbot Medical Inc. is a medical device company, engages in the research, design, and development of robotic endoluminal surgery devices targeting the minimally invasive surgery space. The company offers LIBERTY, an endovascular robotic surgical system designed to maneuver guidewires and over-the-wire devices such as microcatheters within the body’s vasculature for use in cardiovascular, peripheral, endovascular, and neurovascular operations. It also provides NovaCross, an intellectual property and technology in the field of intraluminal revascularization devices with anchoring mechanism and integrated microcatheter. The company has a collaboration agreement with Corewell Health for the development of LIBERTY endovascular robotic system; and Emory University, in connection with autonomous robotics in endovascular procedures. Microbot Medical Inc. was founded in 2010 and is based in Hingham, Massachusetts
Similar Companies
| Name |
Market Cap (USD)
diff.
|
PE | Country |
|---|---|---|---|
NASDAQ: AMGN
|
$182.42B
133K%
|
23.9
|
|
NASDAQ: GILD
|
$159.92B
117K%
|
19.0
|
|
NASDAQ: NTRA
|
$27.6B
20K%
|
-
|
|
NYSE: IQV
|
$26.3B
19K%
|
20.0
|
|
NASDAQ: UTHR
|
$25.03B
18K%
|
20.4
|
|
NASDAQ: MRNA
|
$18.13B
13K%
|
-
|
| Name |
Market Cap (USD)
diff.
|
PE | Country |
|---|---|---|---|
EBR: ARGX
|
$47.84B
35K%
41.39B EUR
|
39.9
|
|
KRX: 207940
|
$44.84B
33K%
68.19T KRW
|
35.5
|
|
ASX: CSL
|
$42.36B
31K%
60.27B AUD
|
29.3
|
|
SIX: LONN
|
$42.3B
31K%
33.71B CHF
|
37.2
|
|
KRX: 068270
|
$28.11B
20K%
42.76T KRW
|
43.8
|
|
NASDAQ: BNTX
|
$25.69B
19K%
|
-
|
chevron_leftBack